Nano Dimension Ltd.
NNDM- Exchange
- Nasdaq
- Industry
- Printed Circuit Boards
- SEC CIK
- 0001643303
No open-market purchases or sales by Nano Dimension Ltd. insiders were filed in the last 90 days; 105 institutions reported holding it in 13F filings for Q2 2026, worth $97.4M in total; ARK Invest is the only superinvestor holding it.
Holders of 5% or more of NNDM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nano Dimension Ltd., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 13D/A | 5.20%10.9M shares | +0.20 ppfrom 5.00% | Jan 29, 20262 filings | Feb 19, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Nano Dimension Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 20269:50 PM ET | Oramed Pharmaceuticals Inc. | 13D/A | 5.20%10.9M shares | +0.20 ppfrom 5.00% | Feb 17, 2026 | SEC |
| Jan 29, 20264:44 PM ET | Oramed Pharmaceuticals Inc.and 1 other | 13D | 5.00%10.5M shares | New | Jan 29, 2026 | SEC |
| Jul 14, 20255:42 PM ET | Anson Funds Management LPand 5 others | 13D/A | 4.20%9.06M shares | −3.30 ppfrom 7.50%Below 5% | Jul 11, 2025 | SEC |
| Jul 3, 20256:54 PM ET | Anson Funds Management LPand 5 others | 13D/A | 7.50%16.4M shares | – | Jun 26, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Nano Dimension Ltd. shares.
No Form 144 notices for Nano Dimension Ltd. are on file.